Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 6/20 | 0.50 |
| ▸ | ESR1 | P03372 | 5/20 | 0.43 |
| ▸ | GHSR | Q92847 | 9/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | DRD1 | P21728 | 1/20 | 0.42 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30645344 | 0.88 | ESR2 (0.51) | ESR2ESR1GHSRDRD2DRD1 | |
| SCHEMBL24528881 | 0.88 | ESR2 (0.51) | ESR2ESR1GHSRDRD2DRD1 | |
| SCHEMBL3864665 | 0.86 | ESR2 (0.47) | ESR2ESR1GHSRDRD2DRD1 | |
| SCHEMBL8513232 | 0.85 | ESR2 (0.47) | ESR2ESR1GHSRDRD2DRD1 | |
| SCHEMBL25896301 | 0.85 | GPR119 (0.41) | GHSR | |
| SCHEMBL2081445 | 0.81 | ESR2 (0.49) | ESR2ESR1GHSR | |
| SCHEMBL31505338 | 0.81 | ESR2 (0.56) | ESR2ESR1GHSRDRD2DRD1 | |
| SCHEMBL31505408 | 0.81 | ESR2 (0.56) | ESR2ESR1GHSRDRD2DRD1 | |
| SCHEMBL30645355 | 0.81 | ESR2 (0.56) | ESR2ESR1GHSRDRD2DRD1 | |
| SCHEMBL24528817 | 0.81 | ESR2 (0.56) | ESR2ESR1GHSRDRD2DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192620-A1 | ANILINE COMPOUND USED AS RORy REGULATOR | SHANGHAI LITEDD CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192620-A1 | ANILINE COMPOUND USED AS RORy REGULATOR | RORB, RORA, RORC | ESR2 342/4885ESR1 1922/4885GHSR 691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.